The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
Please provide your email address to receive an email when new articles are posted on . In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to ...
Highlights: Designed to transform clinical trial operations for sponsors, sites and study teamsPersona driven, AI-powered solutions automate ...
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is ...
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by ...
There seems to be a modern day gold rush as companies explore how to use machine learning in clinical decision support software. Unfortunately for libertarians, FDA will regulate some of that software ...
CD8+ T cell proximity analysis of the tumor microenvironment (TME) in patients with pancreatic ductal adenocarcinoma (PDAC) and associated clinical outcomes. This is an ASCO Meeting Abstract from the ...
TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...
Artificial Intelligence (AI) and Machine Learning (ML) in pediatrics represent a burgeoning field within healthcare, driven ...
Sepsis is one of the most common and lethal syndromes encountered in intensive care units (ICUs), and acute respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results